Each dispersible tablet contains Cefixime 200 mg.

Gramocef-O 200 Dispersible Tablets contain Cefixime, a third-generation oral cephalosporin antibiotic with broad-spectrum bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. The dispersible tablet formulation offers convenient administration and improved patient compliance. Cefixime is effective in the treatment of common bacterial infections, including urinary tract infections, respiratory tract infections, and typhoid fever. Its proven efficacy, favorable safety profile, and convenient dosing schedule make it a valuable option in antimicrobial therapy.

Gramocef-O 200 Dispersible Tablets are indicated for the treatment of urinary tract infections (UTIs), respiratory tract infections (RTIs), and typhoid fever caused by susceptible bacterial organisms.

Cefixime is a semi-synthetic, oral third-generation cephalosporin antibiotic that exhibits potent bactericidal activity against a broad spectrum of Gram-positive and Gram-negative bacteria. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, resulting in disruption of cell wall integrity and bacterial cell death. This mechanism provides effective eradication of susceptible pathogens responsible for a variety of community-acquired infections.

For children weighing more than 45 kg, adolescents above 12 years of age, and adults, the recommended dosage is one dispersible tablet every 12 hours or as directed by the physician. The duration of therapy should be based on the type and severity of infection and the patient's clinical response.

Gramocef-O 200 Dispersible Tablets are contraindicated in patients with known hypersensitivity to Cefixime, other cephalosporin antibiotics, or any component of the formulation.